4.7 Article

Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides

期刊

BIOORGANIC & MEDICINAL CHEMISTRY
卷 17, 期 3, 页码 1139-1145

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2008.12.041

关键词

Maslinic acid; Triterpenes; Solid-phase synthesis; Anti-HIV; Peptides

资金

  1. Comision Interministerial de Ciencia y Tecnologia
  2. Ministerio de Educacion y Cultura
  3. Junta de Andalucia [P06-CTS-01353]
  4. Spanish RIS Network 'Red de Investigacion en SIDA' [RD06-0006]

向作者/读者索取更多资源

Maslinic acid (1) has been coupled at C-28 with several alpha- and omega-amino acids by using solution- and solid-phase synthetic procedures. Twelve derivatives (2-13) with a single amino acid residue were prepared in solution phase, whereas a dipeptide (14), a tripeptide (15), and a series of conjugate dipeptides (16-24) were synthesized in solid phase. The anti-HIV activity of these compounds was assessed on MT-2 cells infected with viral clones carrying the luciferase gene as a reporter. While in maslinic acid ( 1) were present both cytotoxic and antiviral activities, only the derivatives 13 and 24 showed anti-HIV-1 activity and therefore represent a novel class of anti-HIV-1 compounds. (C) 2009 Published by Elsevier Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biochemistry & Molecular Biology

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules

Beatriz G. G. de la Torre, Fernando Albericio

Summary: While the world was battling with the COVID-19 Omicron wave at the end of 2021, except for China, most countries ended 2022 with COVID-19 being treated like the flu. As a result, the U.S. Food and Drug Administration (FDA) only authorized 37 new drugs this year, compared to an average of 52 in the previous four years. This marks the second lowest number of drug approvals in the last six years, even though it may change in the future. The decrease in FDA approvals mainly applies to small molecule drugs, while biologics and TIDES have remained relatively constant.

MOLECULES (2023)

Article Medicine, Research & Experimental

VCE-005.1, an hypoxia mimetic betulinic acid derivative, induces angiogenesis and shows efficacy in a murine model of traumatic brain injury

Maria Eugenia Prados, Carmen Navarrete, Adela Garcia-Martin, Isabel Lastres-Cubillo, Francisco Ponce-Diaz, Jose Martinez-Orgado, Eduardo Munoz

Summary: Traumatic brain injury (TBI) is a leading cause of mortality and morbidity worldwide, with neuroinflammation and brain-blood barrier (BBB) disruption playing critical roles in its pathogenesis. In this study, the potential therapeutic effects of VCE-005.1, a betulinic acid hydroxamate, were investigated in vitro and in a TBI mouse model. The results demonstrate that VCE-005.1 stabilizes HIF-1 alpha, enhances TJ protein expression, promotes angiogenesis, improves locomotor coordination, preserves BBB integrity, reduces immune cells infiltration, recovers AMPK expression, and decreases neuronal cell apoptosis in the TBI model, highlighting its multitarget anti-inflammatory and neuroprotective properties.

BIOMEDICINE & PHARMACOTHERAPY (2023)

Article Infectious Diseases

D- and N-Methyl Amino Acids for Modulating the Therapeutic Properties of Antimicrobial Peptides and Lipopeptides

Maria Veronica Humpola, Roque Spinelli, Melina Erben, Virginia Perdomo, Georgina Guadalupe Tonarelli, Fernando Albericio, Alvaro Sebastian Siano

Summary: In this study, analogs of two antimicrobial peptides, C10:0-A2 and TA4, were designed and synthesized, and non-proteinogenic amino acids were used to improve their therapeutic properties. The physicochemical properties and antimicrobial activity of these analogs were analyzed. The results showed that substitution with D- and N-methyl amino acids could enhance stability against enzymatic degradation and modulate the therapeutic properties of antimicrobial peptides and lipopeptides. The study provides insights into the design and optimization of antimicrobial peptides for improved stability and therapeutic efficacy. TA4(dK), C10:0-A2(6-NMeLys), and C10:0-A2(9-NMeLys) were identified as the most promising molecules for further studies.

ANTIBIOTICS-BASEL (2023)

Article Chemistry, Multidisciplinary

Methionine-Containing Peptides: Avoiding Secondary Reactions in the Final Global Deprotection

K. P. Nandhini, Mahama Alhassan, Clinton G. L. Veale, Fernando Albericio, Beatriz G. de la Torre

Summary: The solid-phase synthesis of Met-containing peptides often leads to the formation of impurities, Met(O) and sulfonium salt, due to oxidation and S-alkylation reactions. These reactions occur during the final acidolytic cleavage step. In this study, two new cleavage solutions were developed to eliminate oxidation and reduce S-alkylation. The optimal mixture for Cys-containing peptides was TFA-anisole-TMSCl-Me2S-TIS with triphenyl phosphine, while TIS was not required for other peptides. Both cleavage solutions were effective for sensitive amino acids like Cys and Trp. The sulfonium salt was successfully reversed to free Met-containing peptide by heating with acetic acid.

ACS OMEGA (2023)

Review Biochemistry & Molecular Biology

FDA Approvals of Biologics in 2022

Alexander C. Martins, Fernando Albericio, Beatriz G. de la Torre

Summary: The year 2022 saw the successful control of the COVID-19 pandemic in most countries through social and hygiene measures and vaccination campaigns. However, there was a decrease in total drug approvals by the FDA, particularly for small molecules. The Biologics class, on the other hand, maintained its figures with the authorization of 15 novel molecules.

BIOMEDICINES (2023)

Article Chemistry, Medicinal

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest

Othman Al Musaimi, Danah Al Shaer, Fernando Albericio, Beatriz G. de la Torre

Summary: In 2022, a total of 37 new drug entities were approved, with TIDES class drugs gaining five authorizations, consisting of four peptides and one oligonucleotide. The majority of these drugs (23 out of 37) were first-in-class and received fast-track designation by the FDA. This analysis focuses on the TIDES approved in 2022, examining their chemical structure, medical target, mode of action, administration route, and common adverse effects.

PHARMACEUTICALS (2023)

Article Biotechnology & Applied Microbiology

Peptides, solid-phase synthesis and characterization: Tailor-made methodologies

Fanny Guzman, Monica Arostica, Tanya Roman, Dina Beltran, Adriana Gauna, Fernando Albericio, Constanza Cardenas

Summary: Solid-Phase Peptide Synthesis (SPPS) is a widely used technique in research and production. Three different laboratory protocols have been implemented to fulfill diverse requirements. The results show that each protocol yields different purification and can be chosen based on specific needs.

ELECTRONIC JOURNAL OF BIOTECHNOLOGY (2023)

Article Biochemistry & Molecular Biology

Morpholine, a strong contender for Fmoc removal in solid-phase peptide synthesis

Sinenhlanhla N. Mthembu, Amit Chakraborty, Ralph Schonleber, Fernando Albericio, Beatriz G. de la Torre

Summary: Morpholine, scoring 7.5 in greenness and not being regulated, is a promising candidate for Fmoc removal in solid-phase peptide synthesis (SPPS). Morpholine in dimethylformamide (DMF) (50%-60%) effectively removes Fmoc in SPPS, reduces diketopiperazine formation, and nearly eliminates aspartimide formation. Somatostatin has been successfully synthesized using 50% morpholine in DMF with the same purity as when using 20% piperidine-DMF, serving as proof of concept.

JOURNAL OF PEPTIDE SCIENCE (2023)

Review Chemistry, Multidisciplinary

Antimicrobial Peptide Synergies for Fighting Infectious Diseases

Jessica T. Mhlongo, Ayman Y. Waddad, Fernando Albericio, Beatriz G. de la Torre

Summary: Antimicrobial peptides (AMPs) are promising candidates for combating multidrug resistance due to their heterogenous structures and broad-spectrum action. The combined use of AMPs with other antimicrobial agents provides a new arsenal of drugs with synergistic action, inhibiting the development of drug resistance. This review discusses various synergies of AMPs with antimicrobials and miscellaneous agents, providing guidance for improved clinical outcomes.

ADVANCED SCIENCE (2023)

Review Chemistry, Medicinal

Chemistry and Pharmacology of Fluorinated Drugs Approved by the FDA (2016-2022)

Ghulam Shabir, Aamer Saeed, Wajeeha Zahid, Fatima Naseer, Zainab Riaz, Nafeesa Khalil, Mary J. Muneeba, Fernando Albericio

Summary: Fluorine substitution has been extensively explored for improving drug properties, such as increasing biological activity and enhancing stability. Selective substitution of fluorine onto therapeutic or diagnostic drugs can enhance pharmacokinetic and physicochemical properties. The use of fluorine in radiolabeling and PET imaging has also been studied. This review reports on FDA-approved fluorinated drugs and provides examples from various therapeutic and diagnostic drugs.

PHARMACEUTICALS (2023)

Article Biochemical Research Methods

Improving 2-Chlorotrityl Chloride (2-CTC) Resin Activation

Tanya Roman, Gerardo Acosta, Beatriz G. de la Torre, Constanza Cardenas, Fanny Guzman, Fernando Albericio

Summary: This study presents an optimized procedure for activating 2-chlorotrityl chloride (2-CTC) resin, reducing the use of activation reagent and activation time. It also demonstrates the feasibility of reusing the resin and achieving different degrees of activation by varying the amount of thionyl chloride (SOCl2).

METHODS AND PROTOCOLS (2023)

Article Biochemistry & Molecular Biology

Serinol-Based Versatile Disulfide-Reducing Reagent

Babita Kushwaha, Sinenhlanhla N. Mthembu, Anamika Sharma, Fernando Albericio, Beatriz G. de la Torre

Summary: We have synthesized disulfide-reducing agents DPDT and DMPDT from serinol and methyl serinol, respectively. DPDT demonstrated higher stability than DMPDT. The reducing capacity of DPDT was found to be comparable to that of DTT, and its effectiveness was evaluated in both liquid and solid phases.

MOLECULES (2023)

Review Chemistry, Multidisciplinary

The challenge of peptide nucleic acid synthesis

K. P. Nandhini, Danah Al Shaer, Fernando Albericio, Beatriz G. G. de la Torre

Summary: Peptide Nucleic Acids (PNAs) are important mimics of DNA/RNA that can effectively bind with high affinity and specificity. Due to their metabolic stability, PNAs have broad applications in various fields. However, PNA synthesis faces challenges such as difficulties in preparing monomers and their solubility, as well as obstacles related to intra/inter chain aggregation and side reactions. Different protecting group strategies can be employed to overcome these hurdles and optimize the synthesis process.

CHEMICAL SOCIETY REVIEWS (2023)

Article Chemistry, Organic

A safety-catch protecting group strategy compatible with Boc-chemistry for the synthesis of peptide nucleic acids (PNAs)

K. P. Nandhini, Sikabwe Noki, Edikarlos Brasil, Fernando Albericio, Beatriz G. de la Torre

Summary: Peptide Nucleic Acids (PNAs) are a class of synthetic biomolecules with great potential in medicine. A new PNA SPS strategy based on a safety-catch protecting group scheme has been developed, allowing the synthesis of PNAs using Boc as a temporal protecting group.

ORGANIC & BIOMOLECULAR CHEMISTRY (2023)

Article Chemistry, Multidisciplinary

An experimental and computational investigation of the elusive anhydrous form of Oxyma-B

Rafel Prohens, Rafael Barbas, Beatriz G. de la Torre, Fernando Albericio, Antonio Frontera

Summary: This article reports on the crystal structure and properties of Oxyma-B, an important racemization suppressor for peptide synthesis. Through a combination of experimental and computational methods, the solid-state landscape and hydration tendency of this substance have been revealed.

CRYSTENGCOMM (2023)

暂无数据